Sporadic inclusion-body myositis and hereditary inclusion-body myopathies - Diseases of oxidative stress and aging?

被引:49
作者
Askanas, V [1 ]
Engel, WK [1 ]
机构
[1] Univ So Calif, Sch Med, Good Samaritan Hosp, Dept Neurol,Neuromuscular Ctr, Los Angeles, CA 90017 USA
关键词
D O I
10.1001/archneur.55.7.915
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sporadic inclusion-body myositis and hereditary inclusion-body myopathies are progressive and highly debilitating muscle diseases. The most characteristic morphologic feature of sporadic inclusion-body myositis and hereditary inclusion-body myopathies is vacuolar degeneration of muscle fibers, accompanied by intrafiber clusters ("tangles") of paired-helical filaments and by accumulation of several proteins that are characteristic of a brain of patients with Alzheimer disease. In neither the hereditary inclusion-body myopathies nor sporadic inclusion-body myositis are the sequential steps of the pathogenic cascade understood, The several forms of hereditary inclusion-body myopathies have different genetic transmissions and probably different genetic defects. Because the sporadic inclusion-body myositis and hereditary inclusion-body myopathies have several characteristic pathologic features in common, we postulate that their different causes trigger the same upstream aberration leading to a similar downstream cascade of pathologic events,which are ultimately responsible for the characteristic muscle-fiber degeneration. We propose that important contributory factors leading to the inclusion-body myositis-specific muscle fiber destruction are muscle aging and oxidative stress, putatively induced by the upstream overexpression of P-amyloid precursor protein within abnormal muscle fibers.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 24 条
  • [1] Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1
    Argov, Z
    Tiram, E
    Eisenberg, I
    Sadeh, M
    Seidman, CE
    Seidman, JG
    Karpati, G
    MitraniRosenbaum, S
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (04) : 548 - 551
  • [2] New developments in hereditary inclusion body myopathies
    Askanas, V
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (04) : 421 - 422
  • [3] Fourteen newly recognized proteins at the human neuromuscular junctions - and their nonjunctional accumulation in inclusion-body myositis
    Askanas, V
    Engel, WK
    Alvarez, RB
    [J]. MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 28 - 56
  • [4] ASKANAS V, 1998, INCLUSION BODY MYOSI, P3
  • [5] Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732
  • [6] Askanas Valerie, 1995, Current Opinion in Rheumatology, V7, P486, DOI 10.1097/00002281-199511000-00005
  • [7] Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
  • [8] Broccolini A, 1998, NEUROLOGY, V50, pA367
  • [9] beta-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease
    Butterfield, DA
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (05) : 495 - 506
  • [10] The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis
    Dalakas, MC
    Sivakumar, K
    [J]. CURRENT OPINION IN NEUROLOGY, 1996, 9 (03) : 235 - 239